Lack of Disclosure on Unregistered Equity Sales Clouds Dilution Risks at Kiniksa PharmaceuticalsTip Ranks·4 hours agoKNSA+1.86%
Wedbush Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockMarket Beat·17 hours agoKNSA+1.86%UBS-0.44%
Top Biotech Gainers: KNSA Soars On Q2 Results, TRIB, OPK On Watch, MPLT On The Mend?rttnews·1 day ago, 09:50 PMTRIB+5.86%KNSA+1.86%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·1 day ago, 12:06 PMREPL+1.12%BMY-0.79%
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesdaybenzinga_article·1 day ago, 09:05 AMAWI-2.33%KO+0.92%
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Posts Quarterly Earnings Results, Hits EstimatesMarket Beat·1 day ago, 06:56 AMKNSA+1.86%
Kiniksa Pharmaceuticals | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 243.6 MEarnings Watch·1 day ago, 06:35 AMKNSA+1.86%
Kiniksa Pharmaceuticals to report Q2 2026 results in conference call and webcastPUBT·Jul 23 at 03:03 PMKNSA+1.86%
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst SaysMarket Beat·Jul 13 at 07:18 AMKNSA+1.86%
